Today: 2 March 2026
Browse Category

Stock Market 26 September 2025 - 27 September 2025

Monster Strike x Haruhi Suzumiya Collaboration Leaked: Characters, Dates, and Gameplay Details

Monster Strike x Haruhi Suzumiya Collaboration Leaked: Characters, Dates, and Gameplay Details

Monster Strike is rumored to launch a Haruhi Suzumiya collaboration in mid-August 2025, lasting about two weeks. Expected featured characters include Haruhi, Yuki, Kyon, Mikuru, and Koizumi as new 6★ and 4★ monsters. The event will likely include special quests, limited missions, and gacha with boosted rates for collab units. No official confirmation yet from Monster Strike.
27 September 2025
Canada Goose (GOOS) Stock Skyrockets: Luxury Parka Maker’s Bold Moves, Price Hikes & Buyout Buzz

Canada Goose (GOOS) Stock Skyrockets: Luxury Parka Maker’s Bold Moves, Price Hikes & Buyout Buzz

Canada Goose closed at $13.50 on Sept. 26, 2025, near the top of its 52-week range. Q1 FY2026 revenue rose 22%, but retail expansion costs led to an adjusted loss of C$0.91 per share. Market cap stands at about $1.3 billion, with a trailing P/E of 38. Analysts rate the stock a moderate buy, with an average 12-month target of $15.
Electronic Arts (NASDAQ: EA) – $50 Billion Buyout Buzz Sends Stock Soaring (Sept 2025)

Electronic Arts (NASDAQ: EA) – $50 Billion Buyout Buzz Sends Stock Soaring (Sept 2025)

Electronic Arts shares closed at $193.35 on Sept. 26 after surging 15% on reports of advanced go-private talks led by Silver Lake, Saudi PIF, and Affinity Partners at a $50 billion valuation. EA’s market cap stands near $48.4 billion, with FY2025 revenue at $7.46 billion. The company recently launched skate. and will release Battlefield 6 on Oct. 10. EA repurchased $2.5 billion in shares over the past year.
Coinbase (COIN) Stock Crashes in Crypto Sell-Off – Can It Bounce Back?

Coinbase (COIN) Stock Crashes in Crypto Sell-Off – Can It Bounce Back?

Coinbase closed at $312.59 on Sept. 26, down about 6% from five days earlier, as crypto prices slid and trading volumes fell. Q2 revenue dropped 26% quarter-over-quarter to $1.51 billion, with profit at $33 million, down sharply from a year ago. CEO Brian Armstrong sold 25,000 shares at $322 on Sept. 15. The company’s 52-week range is $142.60 to $444.60, with a market cap near $80.3 billion.
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

The BSE Sensex plunged 2,587 points (3.2%) and the Nifty 50 lost 672 points (2.7%) last week, marking their worst weekly drop in nearly six months. About ₹16 trillion in market capitalization was erased as U.S. President Trump imposed 100% tariffs on imported branded pharma products and sharply raised H-1B visa fees, hitting Indian tech and pharma stocks. IT and pharma sectors each fell around 8%.
27 September 2025
Tata Stock Split Frenzy: Tata Investment Shares Soar 25% in Two Days, Record Date Set – What Investors Should Know

Tata Capital’s $2 Billion IPO: Dates, Valuation, Risks – What Everyone’s Talking About

Tata Capital’s IPO will open October 6, 2025, aiming to raise up to ₹17,200 crore by issuing 47.58 crore shares. The offer includes 21 crore new shares and 26.58 crore for sale, with Tata Sons selling 23 crore and IFC 3.58 crore. The company targets a post-IPO valuation of $16–18 billion. The IPO meets RBI’s deadline for upper-layer NBFCs to list by September 2025.
27 September 2025
Oklo (OKLO) Nuclear Stock Skyrockets 500% on AI Data Center Hype – Bubble or Breakthrough?

Oklo (OKLO) Nuclear Stock Skyrockets 500% on AI Data Center Hype – Bubble or Breakthrough?

Oklo shares traded near $110 on Sept. 26, 2025, up about 550% year-to-date, with market cap reaching roughly $20 billion. The company broke ground on its first 75 MWe Aurora microreactor at Idaho National Lab and won a U.S. Air Force contract for a reactor at Eielson AFB. Oklo remains pre-revenue, reporting a Q1 2025 loss of $0.07 per share on $0 sales. Wall Street consensus rates the stock “Hold” with a $76.50 average target.
Thai Airways (TAWNF) Stock Takes Off: Turnaround Fuels 2025 Rally and Bullish Forecast

Thai Airways (TAWNF) Stock Takes Off: Turnaround Fuels 2025 Rally and Bullish Forecast

Thai Airways resumed trading on August 4, 2025, after a five-year suspension, with shares surging 216% intraday to THB10.50. By August 7, the stock closed at THB13.40, giving the airline a market cap of about THB379 billion. The company emerged from court restructuring in mid-2025, reporting quarterly operating profits since 2023 and a Q2 2025 net profit of THB12.13 billion.
27 September 2025
No, You Won’t Get a Surprise $2,000 Stimulus Check in Late 2025 – Experts Debunk Viral Rumors

No, You Won’t Get a Surprise $2,000 Stimulus Check in Late 2025 – Experts Debunk Viral Rumors

No new federal stimulus checks have been approved, and the IRS confirms no payments of $1,390, $1,702, or $2,000 are coming. Congress has not passed any 2025 stimulus package, and all official statements deny new checks. State relief programs exist but are unrelated to federal stimulus. Officials warn that viral social media claims about new payments are false and often linked to scams.
27 September 2025
Markets Shaken, AI Valuations Soar, Oil Slumps: What You Missed in Business This Weekend

Virginia Tax Rebate Alert: Gov. Youngkin Announces Up to $400 Checks This Fall – Are You Eligible?

Virginia residents who owed state income tax for 2024 and file by Nov. 3, 2025, will receive a one-time rebate—up to $200 for individuals and $400 for joint filers. Rebates will be sent by mid-October for returns filed before July 1, with later filers receiving checks soon after. Any unpaid state or local tax debts will be deducted from the rebate. Eligibility can be checked online starting Sept. 25, 2025.
27 September 2025
AI Stocks Rally Amid Bold Bets and Breakthroughs: Nvidia’s $100B Play, Tesla’s $1T Robotaxi Dream & More

AI Stocks Rally Amid Bold Bets and Breakthroughs: Nvidia’s $100B Play, Tesla’s $1T Robotaxi Dream & More

Nvidia’s potential $100 billion investment in OpenAI triggered a tech equity rally and analyst forecasts of $400 billion in added revenue. Microsoft will integrate Anthropic’s Claude into Copilot, while Meta is testing new AI video and ad tools. U.S. equity funds saw $12 billion in inflows after Nvidia’s news. A federal judge approved a $1.5 billion copyright settlement for authors suing Anthropic.
Tariffs Fail to Derail European Stock Rally as Markets Bounce Back

Tariffs Fail to Derail European Stock Rally as Markets Bounce Back

European stocks rebounded Friday, with the STOXX 600 up 0.8% and Spain’s IBEX 35 jumping 1.3% to a one-week high. Bank and insurance shares led gains; steelmakers surged after the EU announced tariffs on Chinese steel. Oil stocks rose as Russia curbed fuel exports. Automakers slipped on U.S. tariff threats, but most sectors shrugged off trade fears.
27 September 2025
Wall Street Rebound: Fed Relief, Tariff Twists & Tech Surprises (NYSE Highlights Sept 26–27, 2025)

Wall Street Rebound: Fed Relief, Tariff Twists & Tech Surprises (NYSE Highlights Sept 26–27, 2025)

U.S. stocks rebounded Friday, with the Dow up 0.7%, S&P 500 0.6%, and Nasdaq 0.4%, but all three still posted weekly losses. August core PCE inflation matched forecasts at 0.2%. The Fed cut rates for the first time since December and signaled more cuts possible. Trump announced new tariffs on trucks, drugs, and furniture, boosting shares of Paccar and Eli Lilly.
1-Million-Year-Old Skull Found in China Could Rewrite Human Evolution

1-Million-Year-Old Skull Found in China Could Rewrite Human Evolution

Researchers using 3D scanning have dated the Yunxian 2 skull from central China to 940,000–1.1 million years old, showing it belongs to a Denisovan-related lineage, not classic Homo erectus. The findings suggest major human branches split earlier than previously thought. Some experts urge caution, noting the analysis combined data from different skulls. The study links Yunxian 2 to the “Dragon Man” fossil, recently identified as Denisovan.
27 September 2025
Fastest PC Chip Ever? Qualcomm’s New Snapdragon X2 Takes Aim at Apple and Intel

Fastest PC Chip Ever? Qualcomm’s New Snapdragon X2 Takes Aim at Apple and Intel

Qualcomm announced its Snapdragon X2 Elite and Elite Extreme chips for Windows 11 PCs, claiming up to 75% faster CPU performance than rival Intel and AMD laptop processors. The 3 nm chips feature up to 18 cores at 5 GHz, an 80 TOPS NPU for on-device AI, and new remote management via built-in 5G. Laptops and desktops with X2 chips are expected in early 2026. Real-world benchmarks are not yet available.
27 September 2025
Iran’s Rial Crisis Deepens: USD Soars Past 1.08 Million on Black Market Amid Sanctions Fears (قیمت دلار)

Iran’s Rial Crisis Deepens: USD Soars Past 1.08 Million on Black Market Amid Sanctions Fears (قیمت دلار)

On Sept 26, Tehran’s black-market dollar rate hit a record 1,085,000 rials, more than 90% above the official Central Bank rate of 561,700–582,600 rials. The spike followed the UN snapback sanctions waiver’s expiry on Sept 27, fueling fears over Iran’s oil revenue and hard currency. Inflation stands at 35–40%, with the rial losing half its value since early 2024. Iran plans a 10,000:1 redenomination and digital currency rollout.
27 September 2025
PACS Group (NYSE:PACS) Pops After NYSE Reprieve—Is the Nursing‑Home Giant Finally Turning the Corner? [Sep 26, 2025]

PACS Group (NYSE:PACS) Pops After NYSE Reprieve—Is the Nursing‑Home Giant Finally Turning the Corner? [Sep 26, 2025]

PACS Group shares jumped 10.2% to $13.98 after NYSE granted a listing extension through Nov. 19, 2025. The company will restate 1H24 results due to $61–65 million in revenue overstatements tied to Medicare billing. CFO Derick Apt resigned Sept. 2 after an audit found he accepted high-value gifts. Multiple securities-law investigations remain ongoing.
26 September 2025
Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Crinetics Pharmaceuticals shares surged 28% to around $46 on Sept. 26 after the FDA approved its first drug, Palsonify, for acromegaly. Trading volume spiked nearly tenfold amid heavy short-covering. The company plans to launch Palsonify in October at a $290,000 annual list price. Crinetics holds $1.2 billion in cash and no debt, with analysts raising price targets following the approval.
Go toTop